Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PQ-10

Home DrugsPQ-10

Experimental

Small Molecule

PQ-10

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₂₂H₂₁N₅O₃
CAS Number: 927691-21-2
UNII ID: 63643I762J

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
US 9669035 B2Applicant: JANSSEN PHARMACEUTICA NVPriority: 2012
CN
US
2 publications
SMOOTHING HAIR TREATMENT COMPOSITION
WO 2025168722 A1Applicant: UNILEVER IP HOLDINGS B VPriority: 2024
CN
WO
2 publications
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
US 6624157 B2Applicant: BRISTOL MYERS SQUIBB COPriority: 2001
US
一种基于喹啉功能化柱[5]芳烃的金属配位凝胶及其制备与应用
CN 114149367 BApplicant: 西北师范大学Priority: 2021
CN